Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dangles-Marie, V.
Right arrow Articles by Mami-Chouaib, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dangles-Marie, V.
Right arrow Articles by Mami-Chouaib, F.
[Cancer Research 63, 3682-3687, July 1, 2003]
© 2003 American Association for Cancer Research


Immunology

A Three-Dimensional Tumor Cell Defect in Activating Autologous CTLs Is Associated with Inefficient Antigen Presentation Correlated with Heat Shock Protein-70 Down-Regulation1

Virginie Dangles-Marie2, Sophie Richon, Mohamed El Behi, Hamid Echchakir, Guillaume Dorothée, Jérôme Thiery, Pierre Validire, Isabelle Vergnon, Jeanne Menez, Moncef Ladjimi, Salem Chouaib, Dominique Bellet and Fathia Mami-Chouaib3

Centre National de la Recherche Scientifique, Laboratoire d’immunologie des tumeurs, Faculté des sciences pharmaceutiques et biologiques de Paris, Université René Descartes Paris 5, 75006 Paris [V. D-M., S. R., D. B.]; Institut National de la Santé et de la Recherche Médicale, Cytokines et Immunologie des Tumeurs Humaines [M. E. B., H. E., G. D., J. T., I. V., J. M., S. C., F. M-C.], Département de Biologie Oncologique [D. B.], Institut Gustave Roussy, 94805 Villejuif; and Service d’Anatomie-Pathologie, Institut Mutualiste Montsouris [P. V.] and Laboratoire de Biochimie des Signaux Régulateurs Cellulaires et Moléculaires, Centre National de la Recherche Scientifique-Universite Pierre et Marie Curie [M. L.], 75014 Paris, France

We described previously a CTL clone able to lyse the autologous carcinoma cell line IGR-Heu after specific recognition of an HLA-A2/mutated {alpha}-actinin-4 peptide complex. Here, we used IGR-Heu, cultured either as standard two-dimensional monolayers or as three-dimensional spheroids, to further analyze the influence of target architecture on CTL reactivity. Interestingly, we found that changes in the tumor structure from two- to three-dimensional induced a dramatic decrease in its capacity to activate autologous CTL, as measured by IFN-{gamma} and tumor necrosis factor-{alpha} secretion. These functional alterations were attributable neither to MHC class I expression nor to tumor antigen (Ag) down-regulation, because IGR-Heu, cultured as two- or three-dimensional, expressed similar levels of HLA-A2 and {alpha}-actinin-4. More importantly, incubation of three-dimensional cells with synthetic epitope completely restored cytokine release by CTL. This defective Ag presentation correlated with a decrease in heat shock protein (hsp)70 expression by three-dimensional tumors compared with two-dimensional cells. Furthermore, transfection of the tumor cells with hsp70 cDNA completely restored the Ag-presenting potential of spheroids and, therefore, cytokine production by T cells. These data strongly suggest that hsp70 down-regulation in three-dimensional cells may result in tumor resistance to the immune response.




This article has been cited by other articles:


Home page
BloodHome page
L. Hambach, M. Vermeij, A. Buser, Z. Aghai, T. van der Kwast, and E. Goulmy
Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors
Blood, September 1, 2008; 112(5): 1844 - 1852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Chen, X. He, Z. Wang, D. Wu, H. Zhang, C. Xu, H. He, L. Cui, D. Ba, and W. He
Identification of Human T Cell Receptor {gamma}{delta}-recognized Epitopes/Proteins via CDR3{delta} Peptide-based Immunobiochemical Strategy
J. Biol. Chem., May 2, 2008; 283(18): 12528 - 12537.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
R. J. O. Dowling and D. Bienzle
Gene-expression changes induced by Feline immunodeficiency virus infection differ in epithelial cells and lymphocytes
J. Gen. Virol., August 1, 2005; 86(8): 2239 - 2248.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Jalili, M. Makowski, T. Switaj, D. Nowis, G. M. Wilczynski, E. Wilczek, M. Chorazy-Massalska, A. Radzikowska, W. Maslinski, L. Bialy, et al.
Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells
Clin. Cancer Res., July 1, 2004; 10(13): 4498 - 4508.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.